Go Pro

Aveanna Healthcare (AVAH) Competitors

Aveanna Healthcare logo
$12.82 -0.40 (-2.99%)
As of 03:39 PM Eastern
This is a fair market value price provided by Massive. Learn more.

AVAH vs. TEM, FMS, DVA, BTSG, and HNGE

Should you buy Aveanna Healthcare stock or one of its competitors? Aveanna Healthcare's main competitors and comparable companies include Tempus AI (TEM), Fresenius Medical Care AG & Co. KGaA (FMS), DaVita (DVA), BrightSpring Health Services (BTSG), and Hinge Health (HNGE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Aveanna Healthcare compare to Tempus AI?

Tempus AI (NASDAQ:TEM) and Aveanna Healthcare (NASDAQ:AVAH) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

Tempus AI currently has a consensus target price of $69.63, indicating a potential downside of 8.48%. Aveanna Healthcare has a consensus target price of $14.06, indicating a potential upside of 9.59%. Given Aveanna Healthcare's stronger consensus rating and higher probable upside, analysts clearly believe Aveanna Healthcare is more favorable than Tempus AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tempus AI
2 Sell rating(s)
9 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.41
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67

Aveanna Healthcare has a net margin of 10.56% compared to Tempus AI's net margin of -17.77%. Aveanna Healthcare's return on equity of 80.70% beat Tempus AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Tempus AI-17.77% -50.28% -10.33%
Aveanna Healthcare 10.56%80.70%7.42%

24.2% of Tempus AI shares are owned by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are owned by institutional investors. 24.3% of Tempus AI shares are owned by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Tempus AI has a beta of 3.72, suggesting that its share price is 272% more volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.97, suggesting that its share price is 97% more volatile than the broader market.

Aveanna Healthcare has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tempus AI$1.27B10.79-$245.03M-$1.44N/A
Aveanna Healthcare$2.43B1.15$225.03M$1.2310.43

In the previous week, Tempus AI had 36 more articles in the media than Aveanna Healthcare. MarketBeat recorded 40 mentions for Tempus AI and 4 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.60 beat Tempus AI's score of 0.57 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tempus AI
17 Very Positive mention(s)
4 Positive mention(s)
11 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Aveanna Healthcare
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Aveanna Healthcare beats Tempus AI on 12 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to Fresenius Medical Care AG & Co. KGaA?

Aveanna Healthcare (NASDAQ:AVAH) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Aveanna Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aveanna Healthcare$2.43B1.15$225.03M$1.2310.43
Fresenius Medical Care AG & Co. KGaA$22.20B0.54$1.11B$1.9311.63

In the previous week, Aveanna Healthcare had 3 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 4 mentions for Aveanna Healthcare and 1 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.44 beat Aveanna Healthcare's score of 0.60 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aveanna Healthcare
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fresenius Medical Care AG & Co. KGaA
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

88.0% of Aveanna Healthcare shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 5.3% of Aveanna Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Aveanna Healthcare currently has a consensus price target of $14.06, suggesting a potential upside of 9.59%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.57, suggesting a potential upside of 4.99%. Given Aveanna Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Aveanna Healthcare is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.55

Aveanna Healthcare has a net margin of 10.56% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.83%. Aveanna Healthcare's return on equity of 80.70% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Aveanna Healthcare10.56% 80.70% 7.42%
Fresenius Medical Care AG & Co. KGaA 4.83%9.28%4.16%

Aveanna Healthcare has a beta of 1.97, indicating that its stock price is 97% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

Summary

Aveanna Healthcare beats Fresenius Medical Care AG & Co. KGaA on 12 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to DaVita?

DaVita (NYSE:DVA) and Aveanna Healthcare (NASDAQ:AVAH) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

In the previous week, DaVita had 8 more articles in the media than Aveanna Healthcare. MarketBeat recorded 12 mentions for DaVita and 4 mentions for Aveanna Healthcare. DaVita's average media sentiment score of 0.88 beat Aveanna Healthcare's score of 0.60 indicating that DaVita is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DaVita
7 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aveanna Healthcare
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

DaVita has higher revenue and earnings than Aveanna Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DaVita$13.64B0.86$746.80M$12.2215.00
Aveanna Healthcare$2.43B1.15$225.03M$1.2310.43

90.1% of DaVita shares are owned by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are owned by institutional investors. 1.9% of DaVita shares are owned by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

DaVita presently has a consensus target price of $233.43, indicating a potential upside of 27.35%. Aveanna Healthcare has a consensus target price of $14.06, indicating a potential upside of 9.59%. Given DaVita's higher possible upside, analysts clearly believe DaVita is more favorable than Aveanna Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DaVita
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.57
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67

DaVita has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.97, meaning that its stock price is 97% more volatile than the broader market.

Aveanna Healthcare has a net margin of 10.56% compared to DaVita's net margin of 6.05%. Aveanna Healthcare's return on equity of 80.70% beat DaVita's return on equity.

Company Net Margins Return on Equity Return on Assets
DaVita6.05% -217.63% 5.07%
Aveanna Healthcare 10.56%80.70%7.42%

Summary

Aveanna Healthcare beats DaVita on 9 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to BrightSpring Health Services?

Aveanna Healthcare (NASDAQ:AVAH) and BrightSpring Health Services (NASDAQ:BTSG) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability, media sentiment and institutional ownership.

Aveanna Healthcare currently has a consensus target price of $14.06, indicating a potential upside of 9.59%. BrightSpring Health Services has a consensus target price of $70.71, indicating a potential upside of 26.80%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, analysts plainly believe BrightSpring Health Services is more favorable than Aveanna Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
18 Buy rating(s)
2 Strong Buy rating(s)
3.10

In the previous week, Aveanna Healthcare had 2 more articles in the media than BrightSpring Health Services. MarketBeat recorded 4 mentions for Aveanna Healthcare and 2 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.10 beat Aveanna Healthcare's score of 0.60 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aveanna Healthcare
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Aveanna Healthcare has a net margin of 10.56% compared to BrightSpring Health Services' net margin of 2.55%. Aveanna Healthcare's return on equity of 80.70% beat BrightSpring Health Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Aveanna Healthcare10.56% 80.70% 7.42%
BrightSpring Health Services 2.55%16.73%5.24%

88.0% of Aveanna Healthcare shares are owned by institutional investors. 5.3% of Aveanna Healthcare shares are owned by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Aveanna Healthcare has higher earnings, but lower revenue than BrightSpring Health Services. Aveanna Healthcare is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aveanna Healthcare$2.43B1.15$225.03M$1.2310.43
BrightSpring Health Services$12.91B0.85$190.67M$1.6633.59

Aveanna Healthcare has a beta of 1.97, meaning that its share price is 97% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.84, meaning that its share price is 84% more volatile than the broader market.

Summary

Aveanna Healthcare beats BrightSpring Health Services on 9 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to Hinge Health?

Hinge Health (NYSE:HNGE) and Aveanna Healthcare (NASDAQ:AVAH) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.

Aveanna Healthcare has higher revenue and earnings than Hinge Health. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hinge Health$587.86M12.68-$528.26M$1.2872.19
Aveanna Healthcare$2.43B1.15$225.03M$1.2310.43

In the previous week, Hinge Health had 3 more articles in the media than Aveanna Healthcare. MarketBeat recorded 7 mentions for Hinge Health and 4 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.60 beat Hinge Health's score of 0.59 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hinge Health
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aveanna Healthcare
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

88.0% of Aveanna Healthcare shares are owned by institutional investors. 18.9% of Hinge Health shares are owned by company insiders. Comparatively, 5.3% of Aveanna Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Hinge Health has a beta of 1.38, meaning that its stock price is 38% more volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.97, meaning that its stock price is 97% more volatile than the broader market.

Hinge Health presently has a consensus price target of $103.71, indicating a potential upside of 12.24%. Aveanna Healthcare has a consensus price target of $14.06, indicating a potential upside of 9.59%. Given Hinge Health's stronger consensus rating and higher probable upside, research analysts clearly believe Hinge Health is more favorable than Aveanna Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hinge Health
1 Sell rating(s)
2 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.83
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67

Hinge Health has a net margin of 15.15% compared to Aveanna Healthcare's net margin of 10.56%. Aveanna Healthcare's return on equity of 80.70% beat Hinge Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hinge Health15.15% 51.60% 14.16%
Aveanna Healthcare 10.56%80.70%7.42%

Summary

Hinge Health beats Aveanna Healthcare on 10 of the 16 factors compared between the two stocks.

Get Aveanna Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVAH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVAH vs. The Competition

MetricAveanna HealthcareHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$2.79B$9.68B$7.20B$13.10B
Dividend YieldN/A2.61%2.53%13.00%
P/E Ratio10.4134.49274.9625.73
Price / Sales1.154.92644.7485.68
Price / Cash19.49121.8176.3152.02
Price / Book13.795.2210.446.31
Net Income$225.03M$315.70M$3.49B$359.73M
7 Day Performance-10.06%-1.27%0.62%1.52%
1 Month Performance-2.55%-2.65%-3.26%-3.52%
1 Year Performance52.86%11.68%16.28%5.72%

Aveanna Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVAH
Aveanna Healthcare
4.146 of 5 stars
$12.83
-3.0%
$14.06
+9.6%
+57.4%$2.79B$2.43B10.4135,500
TEM
Tempus AI
1.8679 of 5 stars
$68.85
+10.7%
$69.33
+0.7%
-10.1%$12.42B$1.43BN/A3,800
FMS
Fresenius Medical Care AG & Co. KGaA
2.8486 of 5 stars
$22.98
+0.5%
$23.57
+2.6%
-12.2%$12.34B$22.20B11.901,488
DVA
DaVita
4.6595 of 5 stars
$191.09
+0.9%
$233.43
+22.2%
+39.7%$12.19B$14.01B15.6478,000
BTSG
BrightSpring Health Services
4.6901 of 5 stars
$58.84
-2.4%
$70.71
+20.2%
+104.9%$11.64B$14.37B35.4523,500

Related Companies and Tools


This page (NASDAQ:AVAH) was last updated on 9/23/2026 by MarketBeat.com Staff.
From Our Partners